552 related articles for article (PubMed ID: 15612957)
1. Cost impact of COPD in Japan: opportunities and challenges?
Nishimura S; Zaher C
Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
[TBL] [Abstract][Full Text] [Related]
2. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
3. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
4. The economic burden of smoking in California.
Max W; Rice DP; Sung HY; Zhang X; Miller L
Tob Control; 2004 Sep; 13(3):264-7. PubMed ID: 15333882
[TBL] [Abstract][Full Text] [Related]
5. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
Chiang CH
Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
[TBL] [Abstract][Full Text] [Related]
6. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema.
Wilson L; Devine EB; So K
Respir Med; 2000 Mar; 94(3):204-13. PubMed ID: 10783930
[TBL] [Abstract][Full Text] [Related]
7. The economic impact of the introduction of home blood pressure measurement for the diagnosis and treatment of hypertension.
Funahashi J; Ohkubo T; Fukunaga H; Kikuya M; Takada N; Asayama K; Metoki H; Obara T; Inoue R; Hashimoto J; Totsune K; Kobayashi M; Imai Y
Blood Press Monit; 2006 Oct; 11(5):257-67. PubMed ID: 16932035
[TBL] [Abstract][Full Text] [Related]
8. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
Toy EL; Gallagher KF; Stanley EL; Swensen AR; Duh MS
COPD; 2010 Jun; 7(3):214-28. PubMed ID: 20486821
[TBL] [Abstract][Full Text] [Related]
9. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
10. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991.
Jacobson L; Hertzman P; Löfdahl CG; Skoogh BE; Lindgren B
Respir Med; 2000 Mar; 94(3):247-55. PubMed ID: 10783936
[TBL] [Abstract][Full Text] [Related]
11. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
12. The cost of diabetes in Latin America and the Caribbean.
Barceló A; Aedo C; Rajpathak S; Robles S
Bull World Health Organ; 2003; 81(1):19-27. PubMed ID: 12640472
[TBL] [Abstract][Full Text] [Related]
13. The economic impact of overactive bladder syndrome in six Western countries.
Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
[TBL] [Abstract][Full Text] [Related]
14. Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective.
Marton JP; Boulanger L; Friedman M; Dixon D; Wilson J; Menzin J
Respir Med; 2006 Jun; 100(6):996-1005. PubMed ID: 16288858
[TBL] [Abstract][Full Text] [Related]
15. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
[TBL] [Abstract][Full Text] [Related]
16. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
[TBL] [Abstract][Full Text] [Related]
17. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
[TBL] [Abstract][Full Text] [Related]
19. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study.
Lajas C; Abasolo L; Bellajdel B; Hernández-García C; Carmona L; Vargas E; Lázaro P; Jover JA
Arthritis Rheum; 2003 Feb; 49(1):64-70. PubMed ID: 12579595
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of chronic obstructive pulmonary disease.
Teo WS; Tan WS; Chong WF; Abisheganaden J; Lew YJ; Lim TK; Heng BH
Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
